Held on 05 January 2016
JHS Svendgaard Laboratories announced that the Board of Directors of the Company at its meeting held on 05 January 2016, inter alia, has transacted the following businesses:1. Taking into consideration the application money received from some of the proposed allottees, the Board has considered and approved allotment of 1,26,74,748 Fully Convertible Warrants to the persons belonging to the Non-Promoter Category on a preferential basis at an issue price of Rs. 10/- per Warrant in accordance with the provisions of SEBI (ICDR) Regulations, 2009 read with Companies Act, 2013.
2. In terms of the mandate received from the allottees exercising their right of conversion in compliance with the provisions of SEBI (ICDR) Regulations, 2009, the Board has considered and approved part conversion of aforesaid Warrants, to the extent of 32,80,000 Warrants into equivalent no. of Equity Shares of face value of Rs. 10/- each.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
